Government went under the brake for using Avastin with the indication for macular degeneration treatment

As Avastin was switched to drug with insurance reimbursement with the indication for metastatic colorectal cancer in March of this year, government went under the brake for using Avastin with the indication for macular degeneration treatment.

It was known that at the end of last month, National Health Insurance Service sent an official that regulates 'Approval of uninsured drug which exceeded ...